5-Aza-2 '-deoxycytidine (5-Aza-2-Cdr) reverses CpG methylation of the retinoic acid receptor beta (RAR beta) promoter and restores retinoid responsiveness in non M3 acute myelogenous leukemia (AML) blasts.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- November 16, 2001
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1114 Paediatrics and Reproductive Medicine (FoR)
- Immunology (Science Metrix)
published in
- Blood Journal